WatchStock daily readAAPLTue, Oct 20 close1 min read

Apple’s retreat from its recent high leaves it lagging related stocks

Apple fell 1% while related companies posted a median gain of 1.5%, a notable reversal of its recent relative strength. Concerns about iPhone demand and component costs may have contributed to the weakness.

Apple’s 1% decline Tuesday was ordinary for the stock, but its failure to join a rebound in related companies stood out. The comparison group—Alphabet, Microsoft, Dell, Sony and Garmin—posted a median gain of 1.5%, with three stocks rising and two falling. Apple’s 2.5-percentage-point shortfall exceeded the differences within that group. It opened 0.90% below Monday’s close and finished near its session low, leaving most of the day’s loss in place from the start.

The weakness follows a new 52-week closing high on Friday, October 16, two trading days earlier. Apple still held up better over the past five sessions: it lost 0.52%, versus declines of 1.2% for the S&P 500 and 2.1% for the median of the related companies. Tuesday’s change in relative performance was more telling than the scale of selling. Volume was close to normal at 36.4 million shares, compared with a typical 35.0 million.

Analyst concerns about the iPhone business were already public before the opening bell and may have contributed to the weak start. [1] Commentary published during the session reported that an analyst had downgraded Apple to Hold from Buy, citing weaker iPhone shipment expectations and rising memory costs that threaten earnings growth. [2]

A separate report published during the session relayed UBS’s view that September-quarter revenue should broadly meet forecasts, while slowing growth and higher component costs could pressure gross margins and test Apple’s premium valuation. [3] The business risks are straightforward: weaker shipments can slow hardware revenue growth, while more expensive memory and other components can squeeze margins unless Apple offsets those costs.

Generated by Apex Intelligence. Verify key information against the sources. For information and education, not personalized investment advice. See full disclaimer